A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Pharmaceutical CDMO Services industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
Market Segment by Product Application
Innovative Medicine
Patented Drug
Patent Expired Drug
Finally, the report provides detailed profile and data information analysis of leading company.
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Pharmaceutical CDMO Services consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Pharmaceutical CDMO Services market by identifying its various subsegments.
3.Focuses on the key global Pharmaceutical CDMO Services manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Pharmaceutical CDMO Services with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Pharmaceutical CDMO Services submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Pharmaceutical CDMO Services Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Pharmaceutical CDMO Services Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Pharmaceutical CDMO Services Segment by Type
2.1.1 Drug Substance Development and Manufacturing
2.1.2 Specialized Services
2.1.3 Lab-based Services
2.2 Market Analysis by Application
2.2.1 Innovative Medicine
2.2.2 Patented Drug
2.2.3 Patent Expired Drug
2.3 Global Pharmaceutical CDMO Services Market Comparison by Regions (2017-2027)
2.3.1 Global Pharmaceutical CDMO Services Market Size (2017-2027)
2.3.2 North America Pharmaceutical CDMO Services Status and Prospect (2017-2027)
2.3.3 Europe Pharmaceutical CDMO Services Status and Prospect (2017-2027)
2.3.4 China Pharmaceutical CDMO Services Status and Prospect (2017-2027)
2.3.5 Japan Pharmaceutical CDMO Services Status and Prospect (2017-2027)
2.3.6 Southeast Asia Pharmaceutical CDMO Services Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Pharmaceutical CDMO Services Industry Impact
2.5.1 Pharmaceutical CDMO Services Business Impact Assessment - Covid-19
2.5.2 Market Trends and Pharmaceutical CDMO Services Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Pharmaceutical CDMO Services Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Pharmaceutical CDMO Services Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Pharmaceutical CDMO Services Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Pharmaceutical CDMO Services Manufacturer Market Share
3.5 Top 10 Pharmaceutical CDMO Services Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Pharmaceutical CDMO Services Market
3.7 Key Manufacturers Pharmaceutical CDMO Services Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Pharmaceutical CDMO Services Industry Key Manufacturers
4.1 Recipharm AB
4.1.1 Compan Detail
4.1.2 Recipharm AB Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.1.3 Recipharm AB 158 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Recipharm AB News
4.2 AMRI Global
4.2.1 Compan Detail
4.2.2 AMRI Global Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.2.3 AMRI Global Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Recipharm AB News
4.3 Patheon N.V.
4.3.1 Compan Detail
4.3.2 Patheon N.V. Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.3.3 Patheon N.V. Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Patheon N.V. News
4.4 Aenova Group
4.4.1 Compan Detail
4.4.2 Aenova Group Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.4.3 Aenova Group Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Aenova Group News
4.5 Catalent, Inc.
4.5.1 Compan Detail
4.5.2 Aenova Group Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.5.3 Catalent, Inc. Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Catalent, Inc. News
4.6 Amatsigroup
4.6.1 Compan Detail
4.6.2 Amatsigroup Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.6.3 Amatsigroup Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Amatsigroup News
4.7 WuXi AppTec Group
4.7.1 Compan Detail
4.7.2 WuXi AppTec Group Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Strides Pharma Science Limited
4.8.1 Compan Detail
4.8.2 Strides Pharma Science Limited Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Strides Pharma Science Limited News
4.9 Piramal Pharma Solutions
4.9.1 Compan Detail
4.9.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Piramal Pharma Solutions News
4.10 Siegfried Ltd
4.10.1 Compan Detail
4.10.2 Siegfried Ltd Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.10.3 Siegfried Ltd Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Siegfried Ltd News
4.11 Fareva Group
4.11.1 Compan Detail
4.11.2 Fareva Group Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.11.3 Fareva Group Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Fareva Group News
4.12 FAMAR Health Care Services
4.12.1 Compan Detail
4.12.2 FAMAR Health Care Services Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 FAMAR Health Care Services News
5 Global Pharmaceutical CDMO Services Market Segment by Big Type
5.1 Global Pharmaceutical CDMO Services Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Pharmaceutical CDMO Services Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Pharmaceutical CDMO Services Revenue and Market Share by Big Type (2017-2022)
5.2 Drug Substance Development and Manufacturing Sales Growth Rate and Price
5.2.1 Global Drug Substance Development and Manufacturing Sales Growth Rate (2017-2022)
5.2.2 Global Drug Substance Development and Manufacturing Price (2017-2022)
5.3 Specialized Services Sales Growth Rate and Price
5.3.1 Global Specialized Services Sales Growth Rate (2017-2022)
5.3.2 Global Specialized Services Price (2017-2022)
5.4 Lab-based Services Sales Growth Rate and Price
5.4.1 Global Lab-based Services Sales Growth Rate (2017-2022)
5.4.2 Global Lab-based Services Price (2017-2022)
6 Global Pharmaceutical CDMO Services Market Segment by Big Application
6.1 Global Pharmaceutical CDMO Services Sales Market Share by Big Application (2017-2022)
6.2 Innovative Medicine Sales Growth Rate (2017-2022)
6.3 Patented Drug Sales Growth Rate (2017-2022)
6.4 Patent Expired Drug Sales Growth Rate (2017-2022)
7 Global Pharmaceutical CDMO Services Forecast
7.1 Global Pharmaceutical CDMO Services Revenue, Sales and Growth Rate (2022-2027)
7.2 Pharmaceutical CDMO Services Market Forecast by Regions (2022-2027)
7.2.1 North America Pharmaceutical CDMO Services Market Forecast (2022-2027)
7.2.2 Europe Pharmaceutical CDMO Services Market Forecast (2022-2027)
7.2.3 China Pharmaceutical CDMO Services Market Forecast (2022-2027)
7.2.4 Japan Pharmaceutical CDMO Services Market Forecast (2022-2027)
7.2.5 Southeast Asia Pharmaceutical CDMO Services Market Forecast (2022-2027)
7.2.6 Other Regions Pharmaceutical CDMO Services Market Forecast (2022-2027)
7.3 Pharmaceutical CDMO Services Market Forecast by Type (2022-2027)
7.3.1 Global Pharmaceutical CDMO Services Sales Forecast by Type (2022-2027)
7.3.2 Global Pharmaceutical CDMO Services Market Share Forecast by Type (2022-2027)
7.4 Pharmaceutical CDMO Services Market Forecast by Application (2022-2027)
7.4.1 Global Pharmaceutical CDMO Services Sales Forecast by Application (2022-2027)
7.4.2 Global Pharmaceutical CDMO Services Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Pharmaceutical CDMO Services Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Pharmaceutical CDMO Services Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Pharmaceutical CDMO Services
Figure Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical CDMO Services
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Pharmaceutical CDMO Services Market Size by Big Type
Figure Global Market Share of Pharmaceutical CDMO Services by Big Type in 2021
Figure Drug Substance Development and Manufacturing Picture (2017-2022)
Figure Specialized Services Picture (2017-2022)
Global Pharmaceutical CDMO Services Market Size by Big Application
Table Global Pharmaceutical CDMO Services Market Size by Application
Figure Global Pharmaceutical CDMO Services Market Share by Big Application in 2021
Figure Innovative Medicine Picture
Figure Patented Drug Picture
Figure Patent Expired Drug Picture
Table Global Pharmaceutical CDMO Services Comparison by Regions (M USD) (2017-2027)
Figure Global Pharmaceutical CDMO Services Market Size (Million US$) (2017-2027)
Figure North America Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate (2017-2027)
Figure China Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Pharmaceutical CDMO Services Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Pharmaceutical CDMO Services Sales by Manufacturer (2017-2022)
Figure Global Pharmaceutical CDMO Services Sales Market Share by Manufacturer in 2021
Table Global Pharmaceutical CDMO Services Revenue by Manufacturer (2017-2022)
Figure Global Pharmaceutical CDMO Services Revenue Market Share by Manufacturer in 2021
Table Global Pharmaceutical CDMO Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Pharmaceutical CDMO Services Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Pharmaceutical CDMO Services Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Pharmaceutical CDMO Services Market
Table Key Manufacturers Pharmaceutical CDMO Services Product Type
Table Mergers & Acquisitions Planning
Table Recipharm AB Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Recipharm AB
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table AMRI Global Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of AMRI Global
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AMRI Global Recent Development
Table Patheon N.V. Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Patheon N.V.
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Patheon N.V. Main Business
Table Patheon N.V. Recent Development
Table Aenova Group Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Aenova Group
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aenova Group Main Business
Table Aenova Group Recent Development
Table Aenova Group Main Business
Table Aenova Group Recent Development
Table Catalent, Inc. Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Catalent, Inc.
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Catalent, Inc. Main Business
Table Catalent, Inc. Recent Development
Table Amatsigroup Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Amatsigroup
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Amatsigroup Main Business
Table Amatsigroup Recent Development
Table WuXi AppTec Group Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of WuXi AppTec Group
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table WuXi AppTec Group Main Business
Table WuXi AppTec Group Recent Development
Table Strides Pharma Science Limited Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Strides Pharma Science Limited
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Strides Pharma Science Limited Main Business
Table Strides Pharma Science Limited Recent Development
Table Piramal Pharma Solutions Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Piramal Pharma Solutions
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Piramal Pharma Solutions Main Business
Table Piramal Pharma Solutions Recent Development
Table Siegfried Ltd Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Siegfried Ltd
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Siegfried Ltd Main Business
Table Siegfried Ltd Recent Development
Table Fareva Group Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Fareva Group
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Fareva Group Main Business
Table Fareva Group Recent Development
Table FAMAR Health Care Services Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of FAMAR Health Care Services
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table FAMAR Health Care Services Main Business
Table FAMAR Health Care Services Recent Development
Figure Global Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Global Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2022)
Table Global Pharmaceutical CDMO Services Sales by Regions (2017-2022)
Figure Global Pharmaceutical CDMO Services Sales Market Share by Regions in 2021
Table Global Pharmaceutical CDMO Services Revenue by Regions (2017-2022)
Figure Global Pharmaceutical CDMO Services Revenue Market Share by Regions in 2021
Figure North America Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Europe Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure China Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Japan Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Southeast Asia Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Other Regions Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Table Global Pharmaceutical CDMO Services Sales by Big Type (2017-2022)
Table Global Pharmaceutical CDMO Services Sales Market Share by Big Type (2017-2022)
Figure Global Pharmaceutical CDMO Services Sales Market Share by Big Type in 2019
Table Global Pharmaceutical CDMO Services Revenue by Big Type (2017-2022)
Table Global Pharmaceutical CDMO Services Revenue Market Share by Big Type (2017-2022)
Table Global Pharmaceutical CDMO Services Revenue Market Share by Big Type in 2019
Figure Global Drug Substance Development and Manufacturing Sales Growth Rate (2017-2022)
Figure Global Drug Substance Development and Manufacturing Price (2017-2022)
Figure Global Specialized Services Sales Growth Rate (2017-2022)
Figure Global Specialized Services Price (2017-2022)
Figure Global Lab-based Services Sales Growth Rate (2017-2022)
Table Global Pharmaceutical CDMO Services Sales by Big Application (2017-2022)
Table Global Pharmaceutical CDMO Services Sales Market Share by Big Application (2017-2022)
Figure Global Pharmaceutical CDMO Services Sales Market Share by Big Application in 2019
Figure Global Innovative Medicine Sales Growth Rate (2017-2022)
Figure Global Patented Drug Sales Growth Rate (2017-2022)
Figure Global Patent Expired Drug Sales Growth Rate (2017-2022)
Figure Global Pharmaceutical CDMO Services Sales and Growth Rate (2022-2027)
Figure Global Pharmaceutical CDMO Services Revenue and Growth Rate (2022-2027)
Table Global Pharmaceutical CDMO Services Sales Forecast by Regions (2022-2027)
Table Global Pharmaceutical CDMO Services Market Share Forecast by Regions (2022-2027)
Figure North America Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Figure Europe Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Figure China Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Figure Japan Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Figure Southeast Asia Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Figure Other Regions Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Table Global Pharmaceutical CDMO Services Sales Forecast by Type (2022-2027)
Table Global Pharmaceutical CDMO Services Market Share Forecast by Type (2022-2027)
Table Global Pharmaceutical CDMO Services Sales Forecast by Application (2022-2027)
Table Global Pharmaceutical CDMO Services Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pharmaceutical CDMO Services
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Pharmaceutical CDMO Services Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Pharmaceutical CDMO Services Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Pharmaceutical CDMO Services Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Pharmaceutical CDMO Services Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd